Terms: = Breast cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Staging
19 results:
1. N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on breast cancer.
Song Y; Zheng C; Tao Y; Huang R; Zhang Q
Med Sci Monit; 2021 Aug; 27():e929615. PubMed ID: 34349094
[TBL] [Abstract] [Full Text] [Related]
2. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid-derived suppressor cells promote epithelial ovarian cancer cell stemness by inducing the CSF2/p-STAT3 signalling pathway.
Li X; Wang J; Wu W; Gao H; Liu N; Zhan G; Li L; Han L; Guo X
FEBS J; 2020 Dec; 287(23):5218-5235. PubMed ID: 32239647
[TBL] [Abstract] [Full Text] [Related]
4. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
[TBL] [Abstract] [Full Text] [Related]
5. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
[TBL] [Abstract] [Full Text] [Related]
6. Nodal metastasis signatures in breast cancer.
Park K; Lee JH; Han HH; Mun SG; Kang S; Cha YJ; Koo JS; Kim MJ; Lee HS; Moon J; Cho NH
Pathol Res Pract; 2017 Jun; 213(6):680-687. PubMed ID: 28476377
[TBL] [Abstract] [Full Text] [Related]
7. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract] [Full Text] [Related]
8. Parafibromin expression is an independent prognostic factor for colorectal carcinomas.
Zheng HC; Wei ZL; Xu XY; Nie XC; Yang X; Takahashi H; Takano Y
Hum Pathol; 2011 Aug; 42(8):1089-102. PubMed ID: 21315421
[TBL] [Abstract] [Full Text] [Related]
9. Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.
Ismail MF; Aly MS; Khaled HM; Mohamed HM
Ger Med Sci; 2009 May; 7():Doc03. PubMed ID: 19675743
[TBL] [Abstract] [Full Text] [Related]
10. [Activity of the National Oncology R&D Consortium in 2004].
Tímár J;
Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
[TBL] [Abstract] [Full Text] [Related]
11. Detection of Her2/neu, c-myc and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
[TBL] [Abstract] [Full Text] [Related]
12. Expression of c-erbB-2, p53 and c-myc proteins in male breast carcinoma: Comparison with traditional prognostic factors and survival.
Mourão Netto M; Logullo AF; Nonogaki S; Brentani RR; Brentani MM
Braz J Med Biol Res; 2001 Jul; 34(7):887-94. PubMed ID: 11449307
[TBL] [Abstract] [Full Text] [Related]
13. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel.
Mitas M; Mikhitarian K; Walters C; Baron PL; Elliott BM; Brothers TE; Robison JG; Metcalf JS; Palesch YY; Zhang Z; Gillanders WE; Cole DJ
Int J Cancer; 2001 Jul; 93(2):162-71. PubMed ID: 11410861
[TBL] [Abstract] [Full Text] [Related]
14. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.
Lockett MA; Baron PL; O'Brien PH; Elliott BM; Robison JG; Maitre N; Metcalf JS; Cole DJ
J Am Coll Surg; 1998 Jul; 187(1):9-16. PubMed ID: 9660019
[TBL] [Abstract] [Full Text] [Related]
15. Laboratory study of breast cancer using conventional and molecular cytogenetics.
Mark HF; Bland KI
Med Health R I; 1996 Feb; 79(2):50-4. PubMed ID: 8907151
[TBL] [Abstract] [Full Text] [Related]
16. Preferred genetic evolutionary sequences in human breast cancer: a case study.
Shackney SE; Smith CA; Pollice AA; Janocko LE; Singh SG; Groft DW; Brown KA; Hartsock RJ
Cytometry; 1995 Sep; 21(1):6-13. PubMed ID: 8529472
[TBL] [Abstract] [Full Text] [Related]
17. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract] [Full Text] [Related]
18. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract] [Full Text] [Related]
19. [Oncogenes and their significance for head and neck cancers].
Issing WJ; Wustrow TP; Heppt W
HNO; 1992 Aug; 40(8):283-91. PubMed ID: 1517116
[TBL] [Abstract] [Full Text] [Related]
